Emerald Advisers, LLC Haemonetics Corp Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$81.24 - $97.37 $5.23 Million - $6.26 Million	-64,329 Reduced 49.32%	66,108 $5.47 Million
Q1 2024 May 08, 2024	SELL	$71.24 - $85.35 $1.2 Million - $1.44 Million	-16,877 Reduced 11.46%	130,437 $11.1 Million
Q4 2023 Feb 05, 2024	SELL	$80.59 - $92.61 $334,367 - $384,238	-4,149 Reduced 2.74%	147,314 $12.6 Million
Q3 2023 Oct 26, 2023	SELL	$82.56 - $93.49 $1.93 Million - $2.19 Million	-23,387 Reduced 13.38%	151,463 $13.6 Million
Q2 2023 Jul 25, 2023	BUY	$80.84 - $89.45 $29,991 - $33,185	371 Added 0.21%	174,850 $14.9 Million
Q1 2023 May 04, 2023	SELL	$72.75 - $90.6 $123,311 - $153,567	-1,695 Reduced 0.96%	174,479 $14.4 Million
Q4 2022 Feb 03, 2023	SELL	$73.85 - $86.14 $10.7 Million - $12.5 Million	-145,097 Reduced 45.16%	176,174 $13.9 Million
Q3 2022 Oct 25, 2022	BUY	$63.3 - $78.66 $5,633 - $7,000	89 Added 0.03%	321,271 $23.8 Million
Q2 2022 Jul 29, 2022	BUY	$49.27 - $66.08 $2.64 Million - $3.54 Million	53,634 Added 20.05%	321,182 $20.9 Million
Q1 2022 Apr 29, 2022	BUY	$43.77 - $63.22 $11.7 Million - $16.9 Million	267,548 New	267,548 $16.9 Million
Q3 2020 Oct 28, 2020	SELL	$75.65 - $93.58 $6.64 Million - $8.22 Million	-87,835 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$84.96 - $118.91 $15.8 Million - $22.2 Million	-186,315 Reduced 67.96%	87,835 $7.87 Million
Q1 2020 Apr 30, 2020	BUY	$74.34 - $121.82 $1.91 Million - $3.12 Million	25,630 Added 10.31%	274,150 $27.3 Million
Q4 2019 Jan 29, 2020	BUY	$114.37 - $129.46 $5.13 Million - $5.81 Million	44,880 Added 22.04%	248,520 $28.6 Million
Q3 2019 Oct 31, 2019	BUY	$117.16 - $138.52 $2.63 Million - $3.11 Million	22,470 Added 12.4%	203,640 $25.7 Million
Q2 2019 Jul 31, 2019	BUY	$81.74 - $120.34 $2 Million - $2.94 Million	24,410 Added 15.57%	181,170 $21.8 Million
Q1 2019 May 01, 2019	BUY	$83.25 - $102.12 $2.34 Million - $2.87 Million	28,153 Added 21.89%	156,760 $13.7 Million
Q4 2018 Jan 30, 2019	BUY	$90.66 - $116.63 $11.7 Million - $15 Million	128,607 New	128,607 $12.9 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$450 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$390 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$335 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$317 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$304 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account